Show simple item record

Candida endophthalmitis associated with intraocular lens implantation: efficacy of fluconazole therapy

dc.contributor.authorKauffman, Carol A.en_US
dc.contributor.authorBradley, Suzanne F.en_US
dc.contributor.authorVine, Andrew K.en_US
dc.date.accessioned2010-06-01T21:15:20Z
dc.date.available2010-06-01T21:15:20Z
dc.date.issued1993-01en_US
dc.identifier.citationKauffman, Carol A.; Bradley, Suzanne F.; Vine, A. K. (1993). " Candida endophthalmitis associated with intraocular lens implantation: efficacy of fluconazole therapy." Mycoses 36(1-2): 13-17. <http://hdl.handle.net/2027.42/74328>en_US
dc.identifier.issn0933-7407en_US
dc.identifier.issn1439-0507en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74328
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8316256&dopt=citationen_US
dc.description.abstractFour patients with Candida parapsilosis endophthalmitis following intraocular lens implantation were treated with oral fluconazole. All had failed prior therapy with intravitreal amphotericin B. The only patient who had the lens implant removed was cured after treatment with fluconazole for one year. Three patients who did not have the lens implant removed had resolution of symptoms and return of visual acuity towards normal during the year they were on fluconazole. However, five months after therapy had been stopped, all three had decreasing visual acuity, and in two, culture of vitreous fluid yielded C. parapsilosis . Fluconazole may be effective for treatment of endophthalmitis associated with an intraocular lens implant, but only when the implant is removed also. Zusammenfassung . Vier Patienten mit Candida parapsilosis -Endophthalmitis nach intraokulÄrer Linsenimplantation wurden oral mit Fluconazol behandelt. Rei allen Patienten hatte die vorherige intravitreale Amphotericin B-Therapie versagt. Einem Patienten wurde die implantierte Linse entfernt; er war nach einjÄhriger Fluconazol-Therapie geheilt. Den drei ande-ren Patienten wurde die implantierte Linse nicht entfernt. Unter einjÄhriger Fluconazol-Therapie besserten sich zwar die Symptome, und die SehschÄrfe normalisierte sich. FÜnf Monate nach Beendigung der Therapie verschlechterte sich jedoch bei allen drei Patienten die SehfÄhigkeit wieder, und bei zwei von ihnen konnte aus der Glaskorperflussigkeit wieder C. parapsilosis isoliert werden. Fluconazol kann also bei Endophthalmitis nach Linsenimplantation wirksam sein, jedoch nur wenn das Implantat wieder entfernt wird.en_US
dc.format.extent458689 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1993 Blackwell Publishingen_US
dc.subject.otherCandida Parapsilosisen_US
dc.subject.otherEndophthalmitisen_US
dc.subject.otherIntraocular Lens Implanten_US
dc.subject.otherFluconazoleen_US
dc.subject.otherAntimycotic Chemotherapyen_US
dc.subject.otherCandida Parapsilosisen_US
dc.subject.otherEndophthalmitisen_US
dc.subject.otherIntraokulÄRe Linsenimplantationen_US
dc.subject.otherFluconazolen_US
dc.subject.otherAntimykotische Chemotherapieen_US
dc.titleCandida endophthalmitis associated with intraocular lens implantation: efficacy of fluconazole therapyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDentistryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Veterans Affairs Medical Center, Ann Arbor, Michigan, USA.en_US
dc.contributor.affiliationumDivision of Infectious Diseases, Department of Internal Medicine, Ann Arbor, Michigan, USA.en_US
dc.contributor.affiliationumDepartment of Ophthalmology, University of Michigan Medical School, Ann Arbor, Michigan, USA.en_US
dc.identifier.pmid8316256en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74328/1/j.1439-0507.1993.tb00681.x.pdf
dc.identifier.doi10.1111/j.1439-0507.1993.tb00681.xen_US
dc.identifier.sourceMycosesen_US
dc.identifier.citedreferenceMcCray, E., Rampell, N., Solomon, J. L., Bond, W. W., Martone, W. J. & O'Day, D. ( 1986 ) Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J. Clin. Microbiol. 24, 625 – 628.en_US
dc.identifier.citedreferenceStern, W. H., Tamura, E., Jacobs, R. A. et al. ( 1985 ) Epidemic post-surgical Candida parapsilosis endophthalmitis. Ophthalmology 92, 1701 – 1709.en_US
dc.identifier.citedreferenceRao, N. A., Nerenberg, A. V. & Foster, D. J. ( 1991 ) Torulopsis candida (Candida famata ) endophthalmitis simulating Propionobacterium acnes syndrome. Arch. Ophthalmol. 109, 1718 – 1721.en_US
dc.identifier.citedreferencePettit, T. H., Olson, R. J., Foos, R. Y. & Martin, W. J. ( 1980 ) Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch. Ophthalmol. 98, 1025 – 1039.en_US
dc.identifier.citedreferenceRummelt, V., Ruprecht, K. W., Boltze, H. J. & Naumann, G. O. H. ( 1991 ) Chronic Alternaria alternula endophthalmitis following intra-ocular lens implantation. Arch. Ophthalmol. 109, 178.en_US
dc.identifier.citedreferenceGilbert, C. M. & Novak, M. A. ( 1984 ) Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant. Am. J. Ophthalmol. 97, 593 – 595.en_US
dc.identifier.citedreferenceGreen, W. R., Bennett, J. E. & Coos, R. D. ( 1965 ) Ocular penetration of amphotericin B. Arch. Ophthalmol. 73, 769 – 775.en_US
dc.identifier.citedreferenceFisher, J. F., Taylor, A. T., Clark, J., Rao, R. & Espinol-Ingroff, A. ( 1983 ) Penetration of amphotericin B into the human eye. J. Infect. Dis. 147, 164.en_US
dc.identifier.citedreferenceSavani, D. V., Perfect, J. R., Cobo, L. M. & Durack, D. T. ( 1987 ) Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthal-mitis. Antimicrob. Agents Chemother. 31, 6 – 10.en_US
dc.identifier.citedreferenceWalsh, T. J., Foulds, G. & Pizzo, P. A. ( 1989 ) Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrob. Agents Chemother. 33, 467 – 469.en_US
dc.identifier.citedreferenceStransky, T. J. ( 1981 ) Postoperative endophthalmitis secondary to Candida parapsilosis. A case treated by vitrec-tomy and intravitreous therapy. Retina 1, 179 – 185.en_US
dc.identifier.citedreferenceRosen, R. & Friedman, A. H. ( 1973 ) Successfully treated postoperative Candida parakrusei endophthalmitis. Am. J. Ophthalmol. 76, 574 – 577.en_US
dc.identifier.citedreferenceWeems, J. J. Jr. ( 1982 ) Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin. Infect. Dis. 14, 756 – 766.en_US
dc.identifier.citedreferenceMeunier-Carpentier, F., Kiehn, T. E. & Armstrong, D. ( 1981 ) Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am. J. Med. 71, 363 – 370.en_US
dc.identifier.citedreferencePlouffe, J. F., Brown, D. G., Silva, J., Eck, T., Stricof, R. L. & Fekety, F. R. ( 1977 ) Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch. Intern. Med. 137, 1686 – 1689.en_US
dc.identifier.citedreferenceKomshien, S. V., Uwaydah, A. K., Sobel J. D. & Crane, L. R. ( 1989 ) Fungemia caused by Candida species and Torulopsis plabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11, 379 – 390.en_US
dc.identifier.citedreferenceEdwards, J. E. & Filler, S. G. ( 1992 ) Current strategies for treating invasive candidiasis: Emphasis on infections in non-neutropenic patients. Clin. Infect. Dis. 14 ( Suppl. 1 ), S106 – S113.en_US
dc.identifier.citedreferenceSchmid, S., Martenet, A. C. & Oelz, O. ( 1991 ) Candida endophthalmitis: Clinical presentation, treatment, and outcome in 23 patients. Infection 19, 21 – 24.en_US
dc.identifier.citedreferenceFiller, S. G., Crislip, M. A., Mayer, C. L. & Edwards, J. E. Jr. ( 1991 ) Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. Antimicrob. Agents Chemother. 35, 288 – 292.en_US
dc.identifier.citedreferencePerraut, L. E. Jr., Perraut, L. E., Bleiman, B. & Lyons, J. ( 1981 ) Successful treatment of Candida albicans endophthalmitis with intravitreal amphotericin B. Arch. Ophthalmol. 99, 1565 – 1567.en_US
dc.identifier.citedreferenceJones, D. B. ( 1978 ) Therapy of postsurgical fungal endophthalmitis. Ophthalmology 85, 357 – 373.en_US
dc.identifier.citedreferenceKauffman, C. A. ( 1992 ) Fungal infections. Clin. Geriatr. Med. 8, 777 – 791.en_US
dc.identifier.citedreferenceVan't Wout, J. W., Mattie, H. & van Furth, R. ( 1988 ) A prospective study of the efficacy of fluconazole (UK 49,858) against deep-seated fungal infections. J. Antimicrob. Chemother. 21, 665 – 672.en_US
dc.identifier.citedreferenceIshibashi, Y. ( 1991 ) Oral fluconazole for endogenous fungal endophthalmitis. XI Congress of the International Society for Human and Animal Mycology, Montreal 1991, p. 140.en_US
dc.identifier.citedreferenceCruciani, M., Di Perri, G., Concia, E. et al. ( 1990 ) Fluconazole and fungal ocular infection. J. Antimicrob. Chemother. 25, 718 – 720.en_US
dc.identifier.citedreferenceFera, G., Maci, A. M., Schiraldi, O., Auteri, P. & Santoro, S. ( 1991 ) Chororetinitis caused by Candida albicans with systemic candidiasis in a patient with acquired immunodeficiency syndrome: Results of a treatment with fluconazole. Curr. Ther. Res. 49, 1103 – 1107.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.